As well as its needed effects, nivolumab (the active ingredient contained in Opdivo) may cause unwanted side effects that require medical attention.
If any of the following side effects occur while taking nivolumab, check with your doctor or nurse immediately:
Some nivolumab side effects may not need any medical attention.
As your body gets used to the medicine these side effects may disappear.
Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:
Very common ( or more): Rash , pruritus , vitiligo , erythema Frequency not reported: Exfoliative dermatitis, erythema multiforme, vitiligo, psoriasis, immune-mediated rash
Very common ( or more): Elevated AST , elevated alkaline phosphatase , elevated ALT Common ( to ): Elevated total bilirubin, immune-mediated hepatitisFrequency not reported: Increased amylase, increased lipase
Very common ( or more): Diarrhea or colitis Common ( to ): Immune-mediated colitis, nausea, vomitingFrequency not reported: Immune-mediated pancreatitis
Very common ( or more): Cough , upper respiratory tract infection Common ( to ): Pneumonitis, immune-mediated pneumonitis, dyspnea
Very common ( or more): Increased serum creatinine Uncommon ( to ): Immune-mediated nephritis, immune-mediated renal dysfunction
Very common ( or more): Peripheral edema Frequency not reported: Ventricular arrhythmia
The most commonly reported adverse reaction in clinical trials was rash; a composite term including the following rashes maculopapular, erythematous, pruritic, follicular, macular, papular, pustular, vesicular, and dermatitis acneiform.
Common ( to ): Hypothyroidism, hyperthyroidismFrequency not reported: Immune-mediated hypopituitarism, immune-mediated hypophysitis
Frequency not reported: Dizziness, peripheral and sensory neuropathy, immune-mediated demyelination, immune-mediated facial and abducens nerve paresis, immune-mediated myasthenic syndrome, immune-mediated encephalitis
Frequency not reported: Infusion-related reactions
Frequency not reported: Iridocyclitis
Very common ( or more): Anorexia Frequency not reported: Immune-mediated adrenal insufficiency, immune-mediated diabetic ketoacidosis
Frequency not reported: Immune-mediated uveitis, immune-mediated autoimmune neuropathy, immune-mediated Guillain-Barre Syndrome
Common ( to ): Musculoskeletal pain, back pain , arthralgia Frequency not reported: Pain in extremity
Very common ( or more): Fatigue Common ( to ): Pyrexia
It is possible that some side effects of Opdivo may not have been reported.
These can be reported to the FDA here.
Always consult a healthcare professional for medical advice.
Back pain
blistering, peeling, or loosening of the skin
chest tightness
chills
constipation
cough
depressed mood
diarrhea
dry skin and hair
feeling cold
fever
flushing
hair loss
headache
hoarseness or husky voice
itching
joint or muscle pain
muscle cramps and stiffness
nausea and vomiting
red, irritated eyes
slowed heartbeat
sore throat
sores, ulcers, or white spots in the mouth or on the lips
trouble breathing
unusual tiredness or weakness
weight gain
Chest pain
dark urine
general feeling of discomfort or illness
light-colored stools
nervousness
pain
sensitivity to heat
stomach cramps
sweating
tenderness
thickening of bronchial secretions
trouble sleeping
upper right abdominal or stomach pain
watery or bloody diarrhea
weight loss
yellow eyes and skin
Bloating
bloody or cloudy urine
blurred vision or other change in vision
darkening of the skin
dizziness
drowsiness
eye pain
fainting
fast heartbeat
indigestion
loss of appetite
mental depression
pains in the stomach, side, or abdomen, possibly radiating to the back
redness of the eye
sensitivity of the eye to light
skin rash
swelling of the face, feet, or lower legs
tearing
Stuffy or runny nose